Introduction to Biomaterials, Second Edition is a practical road map that follows the full development path—from theory to the lab to practical clinical application—helping you understand how biomaterials evolve from fundamentals to real-world therapeutics. This dramatically revised edition emphasizes biocompatibility at the biomaterial-host interface while also addressing testing, statistics, regulatory considerations, and intellectual property.
Key benefits
- Learn end-to-end biomaterials development, connecting theory, lab research, and practical application in clinical therapeutics.
- Deepen biocompatibility understanding at the biomaterial-host interface, including cell-cell interactions, cell-signaling, and inflammatory and complement cascades.
- Apply standardized testing concepts with in vitro and in vivo paradigms aligned with regulatory guidelines.
- Strengthen clinical translation by exploring 13 important classes of biomaterials, including fundamental and applied research, performance properties, synthesis, and testing.
- Stay current on compliance and IP with new biocompatibility issues, metrics and statistics, new legislation for intellectual property, and updated U.S. FDA information relevant to patent applications.
- Use a structured, classroom-ready format across four sections, with extensive references for a comprehensive yet manageable didactic experience.
Who this is for
- Undergraduates seeking a comprehensive introduction to biomaterials with a clear development pathway.
- Working professionals who need an accessible desk reference and instructional text that covers biology, biomechanics, biomaterials interactions, testing, statistics, regulatory considerations, and intellectual property.
Details
- ISBN: 9780071598958, 0071598952
- Edition: 2
- Authors: Mark J. Albritton, Robert A. Malinzak, Trevor R. Pickering
- Publisher: Other Publisher
- Published Date: 2009-02-01
- Pages: 260
Get Introduction to Biomaterials, Second Edition today and build a practical, clinically focused understanding of biomaterials—from host interactions and testing to regulatory and intellectual property considerations.
